Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH

NCT05668754 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Hypersomnia

Interventions

DRUG: Serdexmethylphenidate
OTHER: Placebo

Sponsor

Zevra Therapeutics

Collaborators

[object Object]